Donald Trump unveiled a new 'Most Favoured Nation' policy to cut drug prices in US, raising concerns for Indian medicine manufacturers. Trump claimed that medicinal drug prices may drop by 400-600% as he forced foreign countries to absorb part of cost of lowering the prices. The effect of price cuts on Indian companies depends on which drugs will be affected.